These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 32539659

  • 1. Cutaneous lupus erythematosus: factors related to cutaneous activity and damage in a cohort of 260 patients from A Coruña, Spain.
    Arévalo-Bermúdez MDP, Paradela S, Balboa-Barreiro V, Fonseca E.
    Lupus; 2020 Aug; 29(9):1021-1030. PubMed ID: 32539659
    [Abstract] [Full Text] [Related]

  • 2. Impact of smoking in cutaneous lupus erythematosus.
    Piette EW, Foering KP, Chang AY, Okawa J, Ten Have TR, Feng R, Werth VP.
    Arch Dermatol; 2012 Mar; 148(3):317-22. PubMed ID: 22105815
    [Abstract] [Full Text] [Related]

  • 3. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity.
    Ugarte A, Porta S, Ríos R, Martinez-Zapico A, Ortego-Centeno N, Agesta N, Ruiz-Irastorza G.
    Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998
    [Abstract] [Full Text] [Related]

  • 4. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
    Kreuter A, Gaifullina R, Tigges C, Kirschke J, Altmeyer P, Gambichler T.
    Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
    [Abstract] [Full Text] [Related]

  • 5. Influence of smoking on disease severity and antimalarial therapy in cutaneous lupus erythematosus: analysis of 1002 patients from the EUSCLE database.
    Kuhn A, Sigges J, Biazar C, Ruland V, Patsinakidis N, Landmann A, Amler S, Bonsmann G, EUSCLE coauthors.
    Br J Dermatol; 2014 Sep; 171(3):571-9. PubMed ID: 24673427
    [Abstract] [Full Text] [Related]

  • 6. Natural history of disease activity and damage in patients with cutaneous lupus erythematosus.
    Ker KJ, Teske NM, Feng R, Chong BF, Werth VP.
    J Am Acad Dermatol; 2018 Dec; 79(6):1053-1060.e3. PubMed ID: 29969701
    [Abstract] [Full Text] [Related]

  • 7. Influence of smoking on the efficacy of antimalarials in cutaneous lupus: a meta-analysis of the literature.
    Chasset F, Francès C, Barete S, Amoura Z, Arnaud L.
    J Am Acad Dermatol; 2015 Apr; 72(4):634-9. PubMed ID: 25648824
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI).
    Yokogawa N, Tanikawa A, Amagai M, Kato Y, Momose Y, Arai S, Eto H, Ikeda T, Furukawa F.
    Mod Rheumatol; 2013 Mar; 23(2):318-22. PubMed ID: 22581095
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Optimal use of antimalarials in treating cutaneous lupus erythematosus.
    Wozniacka A, McCauliffe DP.
    Am J Clin Dermatol; 2005 Mar; 6(1):1-11. PubMed ID: 15675885
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antimalarial drug toxicities in patients with cutaneous lupus and dermatomyositis: A retrospective cohort study.
    Mittal L, Zhang L, Feng R, Werth VP.
    J Am Acad Dermatol; 2018 Jan; 78(1):100-106.e1. PubMed ID: 28989103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.